BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND TCF3, E2A, 6929, ENSG00000071564, P15923, MGC129648, MGC129647, ITF1
50 results:

  • 1. The nuclear factor ID3 endows macrophages with a potent anti-tumour activity.
    Deng Z; Loyher PL; Lazarov T; Li L; Shen Z; Bhinder B; Yang H; Zhong Y; Alberdi A; Massague J; Sun JC; Benezra R; Glass CK; Elemento O; Iacobuzio-Donahue CA; Geissmann F
    Nature; 2024 Feb; 626(8000):864-873. PubMed ID: 38326607
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Transcription factor 3 is dysregulated in megakaryocytes in myelofibrosis.
    Collinson RJ; Wilson L; Boey D; Ng ZY; Mirzai B; Chuah HS; Howman R; Grove CS; Malherbe JAJ; Leahy MF; Linden MD; Fuller KA; Erber WN; Guo BB
    Platelets; 2024 Dec; 35(1):2304173. PubMed ID: 38303515
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. ZNF384-Related Fusion Genes in Acute Lymphoblastic Leukemia.
    Zhu L; Bai W; Cheng Q; Fang J
    Cancer Control; 2023; 30():10732748231182787. PubMed ID: 37306722
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. High frequency of heat shock protein 27 overexpression is a highly effective, high-coverage marker for minimal residual disease detection in children with B-cell acute lymphoblastic leukemia.
    Chou SW; Su YH; Lu MY; Chang HH; Yang YL; Lin DT; Lin KH; Coustan-Smith E; Jou ST
    Pediatr Blood Cancer; 2023 Jan; 70(1):e29990. PubMed ID: 36250996
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. MicroRNA gene methylation landscape in pediatric B-cell precursor acute lymphoblastic leukemia.
    Chaber R; Gurgul A; Tabarkiewicz J; Wróbel G; Szmatoła T; Jasielczuk I; Haus O; Lejman M; Rybka B; Ryczan-Krawczyk R; Jaśkowiec A; Paszek S; Potocka N; Arthur CJ; Bal W; Łach K; Kowal A; Zawlik I; Latos-Grażyńska E
    Adv Clin Exp Med; 2022 Mar; 31(3):293-305. PubMed ID: 35092653
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Genetic features of B-cell lymphoblastic lymphoma with tcf3-PBX1.
    Shirai R; Osumi T; Sato-Otsubo A; Nakabayashi K; Mori T; Yoshida M; Yoshida K; Kohri M; Ishihara T; Yasue S; Imamura T; Endo M; Miyamoto S; Ohki K; Sanada M; Kiyokawa N; Ogawa S; Yoshioka T; Hata K; Takagi M; Kato M
    Cancer Rep (Hoboken); 2022 Sep; 5(9):e1559. PubMed ID: 34553842
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Co-occurrence of tcf3-PBX1 gene fusion, and chromosomal aberration in a pediatric pre-B cell acute lymphoblastic leukemia with clitoris swelling: A case report and literature review.
    He GQ; Guo X; Jiang MY; Xu RR; Dai YL; Luo L; Gao J
    Medicine (Baltimore); 2021 Feb; 100(8):e24802. PubMed ID: 33663097
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Recurrent genetic abnormalities detected by FISH in adult B ALL and association with hematological parameters.
    Tarigopula A; Chandrashekar V; Perumal G
    Cancer Rep (Hoboken); 2020 Dec; 3(6):e21290. PubMed ID: 32902203
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. CD304/neuropilin-1 is a very useful and dependable marker for the measurable residual disease assessment of B-cell precursor acute lymphoblastic leukemia.
    Gudapati P; Khanka T; Chatterjee G; Ghogale S; Badrinath Y; Deshpande N; Patil J; Narula G; Shetty D; Banavali S; Patkar NV; Gujral S; Subramanian PG; Tembhare PR
    Cytometry B Clin Cytom; 2020 Jul; 98(4):328-335. PubMed ID: 31944572
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. tcf3-activated LINC00152 exerts oncogenic role in osteosarcoma through regulating miR-1182/CDK14 axis.
    Zheng L; Hu N; Zhou X
    Pathol Res Pract; 2019 Feb; 215(2):373-380. PubMed ID: 30600185
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A novel PAX5 rearrangement in tcf3-PBX1 acute lymphoblastic leukemia: a case report.
    Barbosa TC; Lopes BA; Blunck CB; Mansur MB; Deyl AVS; Emerenciano M; Pombo-de-Oliveira MS
    BMC Med Genomics; 2018 Dec; 11(1):122. PubMed ID: 30563523
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Copy number alterations determined by single nucleotide polymorphism array testing in the clinical laboratory are indicative of gene fusions in pediatric cancer patients.
    Busse TM; Roth JJ; Wilmoth D; Wainwright L; Tooke L; Biegel JA
    Genes Chromosomes Cancer; 2017 Oct; 56(10):730-749. PubMed ID: 28597942
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Ex vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemia.
    Frismantas V; Dobay MP; Rinaldi A; Tchinda J; Dunn SH; Kunz J; Richter-Pechanska P; Marovca B; Pail O; Jenni S; Diaz-Flores E; Chang BH; Brown TJ; Collins RH; Uhrig S; Balasubramanian GP; Bandapalli OR; Higi S; Eugster S; Voegeli P; Delorenzi M; Cario G; Loh ML; Schrappe M; Stanulla M; Kulozik AE; Muckenthaler MU; Saha V; Irving JA; Meisel R; Radimerski T; Von Stackelberg A; Eckert C; Tyner JW; Horvath P; Bornhauser BC; Bourquin JP
    Blood; 2017 Mar; 129(11):e26-e37. PubMed ID: 28122742
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [PCR detection of relevant translocations in pediatric acute lymphoblastic leukemia].
    Guerra-Castillo FX; Ramos-Cervantes MT; Rosel-Pech C; Jiménez-Hernández E; Bekker-Méndez VC
    Rev Med Inst Mex Seguro Soc; 2016; 54 Suppl 3():S302-S308. PubMed ID: 27855054
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Long-term outcome of 6-month maintenance chemotherapy for acute lymphoblastic leukemia in children.
    Kato M; Ishimaru S; Seki M; Yoshida K; Shiraishi Y; Chiba K; Kakiuchi N; Sato Y; Ueno H; Tanaka H; Inukai T; Tomizawa D; Hasegawa D; Osumi T; Arakawa Y; Aoki T; Okuya M; Kaizu K; Kato K; Taneyama Y; Goto H; Taki T; Takagi M; Sanada M; Koh K; Takita J; Miyano S; Ogawa S; Ohara A; Tsuchida M; Manabe A
    Leukemia; 2017 Mar; 31(3):580-584. PubMed ID: 27698447
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Multiplex RT-PCR Assay for Detection of Common Fusion Transcripts in Acute Lymphoblastic Leukemia and Chronic Myeloid Leukemia Cases.
    Limsuwanachot N; Siriboonpiputtana T; Karntisawiwat K; Chareonsirisuthigul T; Chuncharunee S; Rerkamnuaychoke B
    Asian Pac J Cancer Prev; 2016; 17(2):677-84. PubMed ID: 26925663
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Autophagy collaborates with ubiquitination to downregulate oncoprotein e2a/Pbx1 in B-cell acute lymphoblastic leukemia.
    Yuan N; Song L; Lin W; Cao Y; Xu F; Liu S; Zhang A; Wang Z; Li X; Fang Y; Zhang H; Zhao W; Hu S; Wang J; Zhang S
    Blood Cancer J; 2015 Jan; 5(1):e274. PubMed ID: 25615280
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Graft versus leukemia response without graft-versus-host disease elicited by adoptively transferred multivirus-specific T-cells.
    Melenhorst JJ; Castillo P; Hanley PJ; Keller MD; Krance RA; Margolin J; Leen AM; Heslop HE; Barrett AJ; Rooney CM; Bollard CM
    Mol Ther; 2015 Jan; 23(1):179-83. PubMed ID: 25266309
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Id proteins: small molecules, mighty regulators.
    Ling F; Kang B; Sun XH
    Curr Top Dev Biol; 2014; 110():189-216. PubMed ID: 25248477
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. A revised definition for cure of childhood acute lymphoblastic leukemia.
    Pui CH; Pei D; Campana D; Cheng C; Sandlund JT; Bowman WP; Hudson MM; Ribeiro RC; Raimondi SC; Jeha S; Howard SC; Bhojwani D; Inaba H; Rubnitz JE; Metzger ML; Gruber TA; Coustan-Smith E; Downing JR; Leung WH; Relling MV; Evans WE
    Leukemia; 2014 Dec; 28(12):2336-43. PubMed ID: 24781017
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.